203 related articles for article (PubMed ID: 7679033)
21. Inhibition of substance P-induced microvascular leakage by inhaled methoxamine in rat airways.
Larrazet F; Chauveau M; Weber S; Lockhart A; Frossard N
Br J Pharmacol; 1994 Oct; 113(2):649-55. PubMed ID: 7530577
[TBL] [Abstract][Full Text] [Related]
22. Lack of a role for bradykinin in allergen-induced airway microvascular leakage and bronchoconstriction in the guinea pig.
Sakamoto T; Barnes PJ; Chung KF
Inflamm Res; 1996 Mar; 45(3):123-6. PubMed ID: 8689390
[TBL] [Abstract][Full Text] [Related]
23. Effect of neutral endopeptidase inhibitor on bradykinin-induced bronchoconstriction.
Kamijo Y; Hayashi I; Soma K; Ohwada T; Majima M
Life Sci; 2001 Nov; 70(1):1-15. PubMed ID: 11764001
[TBL] [Abstract][Full Text] [Related]
24. Neurogenic plasma leakage in mouse airways.
Baluk P; Thurston G; Murphy TJ; Bunnett NW; McDonald DM
Br J Pharmacol; 1999 Jan; 126(2):522-8. PubMed ID: 10077247
[TBL] [Abstract][Full Text] [Related]
25. Characterization of tachykinin receptors mediating bronchomotor and vasodepressor responses to neuropeptide gamma and substance P in the anaesthetized rabbit.
Yuan L; Burcher E; Nail BS
Pulm Pharmacol Ther; 1998 Feb; 11(1):31-9. PubMed ID: 9802961
[TBL] [Abstract][Full Text] [Related]
26. Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig.
Sakamoto T; Elwood W; Barnes PJ; Chung KF
J Appl Physiol (1985); 1993 Mar; 74(3):1117-22. PubMed ID: 8482649
[TBL] [Abstract][Full Text] [Related]
27. Role of kinins in anaphylactic-induced bronchoconstriction mediated by tachykinins in guinea-pigs.
Ricciardolo FL; Nadel JA; Graf PD; Bertrand C; Yoshihara S; Geppetti P
Br J Pharmacol; 1994 Oct; 113(2):508-12. PubMed ID: 7834202
[TBL] [Abstract][Full Text] [Related]
28. Bradykinin-induced airway responses in guinea pig: effects of inhibition of cyclooxygenase and thromboxane synthetase.
Arakawa H; Kawikova I; Löfdahl CG; Lötvall J
Eur J Pharmacol; 1992 Dec; 229(2-3):131-6. PubMed ID: 1490516
[TBL] [Abstract][Full Text] [Related]
29. The effect of the selective PAF antagonist CIS-19 on PAF- and antigen-induced bronchoconstriction, microvascular leakage and bronchial hyperreactivity in guinea-pigs.
Lin CH; Ko FN; Ishii H; Ishikawa T; Chen IS; Teng CM; Kuo HP
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):210-6. PubMed ID: 9050014
[TBL] [Abstract][Full Text] [Related]
30. Inhaled formoterol inhibits histamine-induced airflow obstruction and airway microvascular leakage.
Tokuyama K; Lötvall JO; Löfdahl CG; Barnes PJ; Chung KF
Eur J Pharmacol; 1991 Jan; 193(1):35-9. PubMed ID: 2050190
[TBL] [Abstract][Full Text] [Related]
31. Responses of lung parenchyma and airways to tachykinin peptides in piglets.
Dreshaj IA; Martin RJ; Miller MJ; Haxhiu MA
J Appl Physiol (1985); 1994 Jul; 77(1):147-51. PubMed ID: 7525526
[TBL] [Abstract][Full Text] [Related]
32. Effect of Hoe 140, a new bradykinin receptor antagonist, on bradykinin- and platelet-activating factor-induced bronchoconstriction and airway microvascular leakage in guinea pig.
Sakamoto T; Elwood W; Barnes PJ; Chung KF
Eur J Pharmacol; 1992 Mar; 213(3):367-73. PubMed ID: 1319919
[TBL] [Abstract][Full Text] [Related]
33. Effect of the NEP inhibitor SCH32615 on airway responses to intravenous substance P in guinea pigs.
Shore SA; Martins MA; Drazen JM
J Appl Physiol (1985); 1992 Nov; 73(5):1847-53. PubMed ID: 1282124
[TBL] [Abstract][Full Text] [Related]
34. Role of thromboxane A2 in airway microvascular leakage induced by inhaled platelet-activating factor.
Tokuyama K; Lötvall JO; Morikawa A; Barnes PJ; Chung KF
J Appl Physiol (1985); 1991 Nov; 71(5):1729-34. PubMed ID: 1837014
[TBL] [Abstract][Full Text] [Related]
35. Role of endogenous nitric oxide in airway microvascular leakage induced by inflammatory mediators.
Kageyama N; Miura M; Ichinose M; Tomaki M; Ishikawa J; Ohuchi Y; Endoh N; Shirato K
Eur Respir J; 1997 Jan; 10(1):13-9. PubMed ID: 9032485
[TBL] [Abstract][Full Text] [Related]
36. Airway neutral endopeptidase-like enzyme modulates tachykinin-induced bronchoconstriction in vivo.
Dusser DJ; Umeno E; Graf PD; Djokic T; Borson DB; Nadel JA
J Appl Physiol (1985); 1988 Dec; 65(6):2585-91. PubMed ID: 2463981
[TBL] [Abstract][Full Text] [Related]
37. Plasma exudation into airways induced by inhaled platelet-activating factor: effect of peptidase inhibition.
Lötvall JO; Elwood W; Tokuyama K; Barnes PJ; Chung KF
Clin Sci (Lond); 1991 Mar; 80(3):241-7. PubMed ID: 1850684
[TBL] [Abstract][Full Text] [Related]
38. In vivo characterization of the tachykinin receptors involved in the direct and indirect bronchoconstrictor effect of tachykinins in two inbred rat strains.
Joos GF; Kips JC; Pauwels RA
Am J Respir Crit Care Med; 1994 May; 149(5):1160-6. PubMed ID: 7513594
[TBL] [Abstract][Full Text] [Related]
39. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.
Floch A; Fardin V; Cavero I
Br J Pharmacol; 1994 Mar; 111(3):759-68. PubMed ID: 7517328
[TBL] [Abstract][Full Text] [Related]
40. Effect of CP-96,345, a non-peptide NK1 receptor antagonist, against substance P-, bradykinin- and allergen-induced airway microvascular leakage and bronchoconstriction in the guinea pig.
Sakamoto T; Barnes PJ; Chung KF
Eur J Pharmacol; 1993 Jan; 231(1):31-8. PubMed ID: 7680318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
